Company Filing History:
1 out of 1,745 
1 out of 29 
1 out of 5,094 
Years Active: 2024
Title: Alexandre Guy - Innovator in Pain Treatment
Introduction
Alexandre Guy is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pain management through his innovative research and development of new therapeutic compounds. His work focuses on the discovery of bacterial compounds with analgesic properties, which hold promise for treating various pain disorders.
Latest Patents
Alexandre Guy holds a patent for "Lipopeptide compounds for the treatment of pain disorders." This invention is based on the discovery of a new bacterial compound that exhibits analgesic properties. The research highlights the mechanisms involved in the analgesic effects of the probiotic strain Nissle 1917 (EcN). The amino fatty acids produced by EcN have been characterized, revealing their potential to inhibit hypersensitivity to colorectal distension induced by capsaicin, a potent nociceptive compound. The compound acts via the GABA B receptor and is capable of crossing the cellular epithelial barrier, such as the intestinal epithelium. This lipopeptide compound, derived from gamma-aminobutyric acid, is aimed at treating both somatic and visceral pain disorders.
Career Highlights
Throughout his career, Alexandre Guy has worked with esteemed institutions, including the National Institute of Health and Medical Research (Institut National De La Sante Et De La Recherche Medicale) and the University Hospital of Toulouse (Centre Hospitalier Universitaire De Toulouse). His research has significantly advanced the understanding of pain mechanisms and potential treatments.
Collaborations
Alexandre has collaborated with notable colleagues, including Nicolas Cenac and Justine Bertrand-Michel. Their combined expertise has contributed to the successful development of innovative pain management solutions.
Conclusion
Alexandre Guy's work in developing lipopeptide compounds represents a significant advancement in the treatment of pain disorders. His innovative research continues to pave the way for new therapeutic options in pain management.